Recurrent SRSF2 mutations in MDS affect both splicing and NMD.

Abstract excerpt

Oncogenic mutations in the RNA splicing factors SRSF2, SF3B1, and U2AF1 are the most frequent class of mutations in myelodysplastic syndromes and are also common in clonal hematopoiesis, acute myeloid leukemia, chronic lymphocytic leukemia, and a variety of solid tumors. They cause genome-wide splicing alterations that affect important regulators of hematopoiesis. Several mRNA isoforms promoted by the various...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to HeLa Cells
• Share to K562 Cells
• Share to Leukemia, Myeloid, Acute